Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study Describing Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)

NCT02839746 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02839746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02839746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study Describing Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
June 13, 2016
Completion date
October 10, 2018
Enrollment
671 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation